Skip to main content
. 2012 Jul 27;7(7):e42321. doi: 10.1371/journal.pone.0042321

Figure 2. XMRV knock down reduces tumorigenicity of 22Rv1 in vivo.

Figure 2

SCID mice (nā€Š=ā€Š6) were s.c. injected with 22Rv1 shLTR1+2, shLTR3 or with 22Rv1 control cells. For each cell line the final tumor amount was nā€Š=ā€Š12. 36d p.i. mice were sacrificed and tumors were analyzed for weight (A) and necrosis (B).